Zim Laboratories Share Price

Zim Laboratories Limited was incorporated in February, 1984 under the name and style of Zim Laboratories Private Limited in Maharashtra. The Company became a Public Limited Company through fresh Certificate of Incorporation issued by the Registrar of Companies, Mumbai. The Company is engaged in the manufacturing of formulation on drugs and pre formulation ingredients in India and marketing and selling these within and outside India. The Pharma Industry is dominated by Multinationals, Large Indian companies and in the lower end of the market large number of units mainly in the SSI sector.During the year 201920, ZIM Health Technologies Limited was acquired, making it a wholly owned subsidiary of the Company. SIA ZIM Laboratories Limited got incorporated as a wholly owned subsidiary in Latvia.In 2023, the Company launched Thinoral (Patented Oral Thin Film technology) as an alternate drug delivery platform across RoW/Pharmerging Markets and EU. The Company entered into a joint venture with an Australian marketing company to launch New Innovative Products (NIP) and Oral Thin Films (OTF) in 2025. The OTF business marked a milestone with its first commercial order supplied in Europe for Sildenafil citrate 50 milligram ODS. The product was launched in Italy and Malta in 2025.

For the full year FY2025–2026, revenue reached ₹384.82 crore and profit touched at ₹12.16 crore.

As of 7 Mar 2026, Zim Laboratories share price is ₹66.7. The stock opened at ₹69 and had closed at ₹68 the previous day. During today’s trading session, Zim Laboratories share price moved between ₹66.52 and ₹68.99, with an average price for the day of ₹67.75. Over the last 52 weeks, the stock has recorded a low of ₹65.52 and a high of ₹127.00. In terms of performance, Zim Laboratories share price has declined by 9.6% over the past six months and has declined by 22.31% over the last year.